Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
4(40%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
9
90%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting220%
active_not_recruiting220%
completed550%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10